239 related articles for article (PubMed ID: 26041846)
1. Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.
Dun MD; Chalkley RJ; Faulkner S; Keene S; Avery-Kiejda KA; Scott RJ; Falkenby LG; Cairns MJ; Larsen MR; Bradshaw RA; Hondermarck H
Mol Cell Proteomics; 2015 Sep; 14(9):2316-30. PubMed ID: 26041846
[TBL] [Abstract][Full Text] [Related]
2. Comparative membrane proteomics analyses of breast cancer cell lines to understand the molecular mechanism of breast cancer brain metastasis.
Peng W; Zhang Y; Zhu R; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2124-2134. PubMed ID: 28523741
[TBL] [Abstract][Full Text] [Related]
3. Integrated Transcriptomics, Proteomics, and Glycomics Reveals the Association between Up-regulation of Sialylated N-glycans/Integrin and Breast Cancer Brain Metastasis.
Peng W; Zhu R; Zhou S; Mirzaei P; Mechref Y
Sci Rep; 2019 Nov; 9(1):17361. PubMed ID: 31758065
[TBL] [Abstract][Full Text] [Related]
4. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
5. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
Klemm F; Bleckmann A; Siam L; Chuang HN; Rietkötter E; Behme D; Schulz M; Schaffrinski M; Schindler S; Trümper L; Kramer F; Beissbarth T; Stadelmann C; Binder C; Pukrop T
Carcinogenesis; 2011 Mar; 32(3):434-42. PubMed ID: 21173432
[TBL] [Abstract][Full Text] [Related]
6. DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer.
Woditschka S; Evans L; Duchnowska R; Reed LT; Palmieri D; Qian Y; Badve S; Sledge G; Gril B; Aladjem MI; Fu H; Flores NM; Gökmen-Polar Y; Biernat W; Szutowicz-Zielińska E; Mandat T; Trojanowski T; Och W; Czartoryska-Arlukowicz B; Jassem J; Mitchell JB; Steeg PS
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24948741
[TBL] [Abstract][Full Text] [Related]
7. A specific gene expression signature for visceral organ metastasis in breast cancer.
Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
[TBL] [Abstract][Full Text] [Related]
8. Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer.
Bouchal P; Dvořáková M; Roumeliotis T; Bortlíček Z; Ihnatová I; Procházková I; Ho JT; Maryáš J; Imrichová H; Budinská E; Vyzula R; Garbis SD; Vojtěšek B; Nenutil R
Mol Cell Proteomics; 2015 Jul; 14(7):1814-30. PubMed ID: 25903579
[TBL] [Abstract][Full Text] [Related]
9. Identification and analysis of signaling networks potentially involved in breast carcinoma metastasis to the brain.
Li F; Glinskii OV; Zhou J; Wilson LS; Barnes S; Anthony DC; Glinsky VV
PLoS One; 2011; 6(7):e21977. PubMed ID: 21779361
[TBL] [Abstract][Full Text] [Related]
10. miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.
Thomsen KG; Terp MG; Lund RR; Søkilde R; Elias D; Bak M; Litman T; Beck HC; Lyng MB; Ditzel HJ
Oncotarget; 2015 Oct; 6(30):29224-39. PubMed ID: 26317550
[TBL] [Abstract][Full Text] [Related]
11. FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.
Martínez-Aranda A; Hernández V; Guney E; Muixí L; Foj R; Baixeras N; Cuadras D; Moreno V; Urruticoechea A; Gil M; Oliva B; Moreno F; González-Suarez E; Vidal N; Andreu X; Seguí MA; Ballester R; Castella E; Sierra A
Oncotarget; 2015 Dec; 6(42):44254-73. PubMed ID: 26497551
[TBL] [Abstract][Full Text] [Related]
12. SILAC-based proteomic profiling of the human MDA-MB-231 metastatic breast cancer cell line in response to the two antitumoral lactoferrin isoforms: the secreted lactoferrin and the intracellular delta-lactoferrin.
Hoedt E; Chaoui K; Huvent I; Mariller C; Monsarrat B; Burlet-Schiltz O; Pierce A
PLoS One; 2014; 9(8):e104563. PubMed ID: 25116916
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
Sereno M; Haskó J; Molnár K; Medina SJ; Reisz Z; Malhó R; Videira M; Tiszlavicz L; Booth SA; Wilhelm I; Krizbai IA; Brito MA
Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767
[TBL] [Abstract][Full Text] [Related]
14. βIII-Tubulin Regulates Breast Cancer Metastases to the Brain.
Kanojia D; Morshed RA; Zhang L; Miska JM; Qiao J; Kim JW; Pytel P; Balyasnikova IV; Lesniak MS; Ahmed AU
Mol Cancer Ther; 2015 May; 14(5):1152-61. PubMed ID: 25724666
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA profile of breast cancer brain metastasis: identification of potential biomarkers and therapeutic targets.
Fu B; Zhang A; Li M; Pan L; Tang W; An M; Liu W; Zhang J
Epigenomics; 2018 Dec; 10(12):1619-1630. PubMed ID: 30810051
[TBL] [Abstract][Full Text] [Related]
16. Expression of metastasis suppressor gene maspin is reduced in breast cancer brain metastases and correlates with the estrogen receptor status.
Stark AM; Schem C; Maass N; Hugo HH; Jonat W; Mehdorn HM; Held-Feindt J
Neurol Res; 2010 Apr; 32(3):303-8. PubMed ID: 19909580
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of brain metastatic cell from triple negative breast cancer: Understanding the molecular events.
Zhou L; Gao HF; Liu DS; Feng JY; Gao DD; Xia W
Gene; 2018 Jan; 640():21-27. PubMed ID: 29024707
[TBL] [Abstract][Full Text] [Related]
18. Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis.
Palmieri D; Fitzgerald D; Shreeve SM; Hua E; Bronder JL; Weil RJ; Davis S; Stark AM; Merino MJ; Kurek R; Mehdorn HM; Davis G; Steinberg SM; Meltzer PS; Aldape K; Steeg PS
Mol Cancer Res; 2009 Sep; 7(9):1438-45. PubMed ID: 19723875
[TBL] [Abstract][Full Text] [Related]
19. Parallel mRNA, proteomics and miRNA expression analysis in cell line models of the intestine.
O'Sullivan F; Keenan J; Aherne S; O'Neill F; Clarke C; Henry M; Meleady P; Breen L; Barron N; Clynes M; Horgan K; Doolan P; Murphy R
World J Gastroenterol; 2017 Nov; 23(41):7369-7386. PubMed ID: 29151691
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes.
Gulluoglu S; Tuysuz EC; Sahin M; Kuskucu A; Kaan Yaltirik C; Ture U; Kucukkaraduman B; Akbar MW; Gure AO; Bayrak OF; Dalan AB
Brain Res; 2018 Dec; 1700():199-210. PubMed ID: 30176243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]